Skip to main content

Roche’s virtual event on key neuromuscular data presented at the Muscular Dystrophy Association (MDA) scientific and clinical conference 2022

Roche has hosted a virtual event on Wednesday, 16 March 2022.

agenda
Agenda:
WelcomeBruno Eschli, Head of Investor Relations
Neuromuscular franchise strategySamir Megateli, Global Franchise Head, Neuromuscular Diseases, Global Product Strategy
Key Data at MDA 2022Paulo Fontoura, Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases Clinical Development
Q&A

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Download Presentation

PDF

Related links

  • Roche's Annual Report 2021

    Investors

    Each day, our breakthrough medicines and innovative diagnostic solutions improve the lives of countless people worldwide. Learn more about our work in 2021.

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions